Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2008-04-23
2010-12-07
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S184100, C424S234100, C424S248100, C424S278100, C435S041000, C435S069100, C435S243000, C435S253100
Reexamination Certificate
active
07846420
ABSTRACT:
The invention relates to vaccine compositions composed of at least oneMycobacterium aviumsubspeciesparatuberculosis(MAP) antigen, or attenuated or killed MAP for use in methods of immunizing a human against a MAP infection, preventing or treating a MAP infection, and preventing a human disease associated with a MAP infection.
REFERENCES:
patent: 6156322 (2000-12-01), Herman-Taylor
patent: 2004/0234533 (2004-11-01), Aldwell et al.
patent: 2004/0260078 (2004-12-01), Herman-Taylor
patent: 2005/0025783 (2005-02-01), Murray et al.
patent: 2005/0232937 (2005-10-01), Willemsen et al.
patent: 2006/0204521 (2006-09-01), Herman-Taylor
Webster's II, New Riverside University Dictionary, Houghton Mifflin Company, Boston, MA , p. 626, 1988.
Dictionary of Microbiology and Molecular Biology, 2ndEdition, John Wiley & Sons, New York, NY, p. 452, 1987.
Stedman's Medical Dictionary, 26thEdition, Williams & Wilkins, Baltimore MD, p. 868, 1995.
Greenstein, Robert J., Lancet Infectious Diseases 2003 3:507-514.
Hermon-Taylor, J., Ital. J Gastroenterol Hepatol 1998 30:607-610.
Borody et al., Digest Liver Dis 2002 34:29-38.
Greenstein, R.J., Genetics, Barrier Function, immunologic & Microbial Pathways. Munster, Germany 2005: 25.
Naser et al., Lancet 2004 364:1039-1044.
Autschblach et al., GUT 1988 29:588-592.
Greenstein, R.J., Genetics, Barrier Function, immunologic & Microbial Pathways. Munster, Germany 2005: 24.
Greenstein, R.J. , Chron's and Colitis Foundation (CCFA) National Research and Clinical Conference. Fourth Annual Advances in Inflammatory Bowel Disease 2005 Miami, FL:211.
Greenstein et al., GUT 1988 29:588-592.
Gilberts et al., Proc. Natl. Acad. Sci. USA 1994 91(126) :12721-12724.
Greenstein & Collins Lancet 2004 364 (9432) : 396-397.
Hines et al., 8thInternational Colloquium on Paratuberculosis 2005, Copenhagen, Denmark pp. 54 and 105.
Uzonna et al., Proc. 75thInternational Colloquium on Paratuberculosis 2002 Bilbao, Spain:41.
Andersen at al., Infection and immunity 1991 59(6):1905-1910.
El-Zaatari et al., Current Microbiology 1994 29 : 177-184.
De Kessel et al., Scand. J. Immunol. 1992 36 : 201-212.
De Kessel et al., Journal of Clinical Microbiology 1993 31(4) :947-954.
Gilot et al., Journal of Bacteriology 1993 175 (15) : 4930-4935.
Silbaq et al., Infection and Immunity 1998 66(11):5576-5579.
Cameron et al., Microbiology 1994 140 : 1977-1982.
El-Zaatari et al., Journal of Clinical Microbiology 1997 35 (7) : 1794-1799.
El-Zaatari et al., Clinical and Diagnostic Laboratory Immunology 1995 2(6) :657-664.
Shinnick, Thomas M., Journal of Bacteriology 1987 169 (3) :1080-1088.
Thole et al., Infection and Immunity 1987 55 (6) :1466-1475.
Thole et al., Infection and Immunity 1988 56 (6) :1633-1640.
Olsen et al., Infection and Immunity 2000 68 (2) : 801-808.
Licata & Tyrrell P.C.
Swartz Rodney P.
LandOfFree
Mycobacterium avium subspecies paratuberculosis vaccines... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycobacterium avium subspecies paratuberculosis vaccines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterium avium subspecies paratuberculosis vaccines... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4216428